Critically, inhibiting FOXC2 by knocking it down or by inhibiting key positive regulators of FOXC2 blocks EMT induction, stemness, and metastasis [9,10,12,13], demonstrating the significance of targeting this critical protein in cancer. This evidence concerns the gene FOXC2 and cancer.